The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Myelodysplastic syndromes: the complexity of stem-cell diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Self-citationInternational scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Proposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,728
Kantarjian, H., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,530
Self-citationNOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Hope, K. J., Jin, L., & Dick, J. E. (2004) · Nature Immunology · doi:10.1038/ni1080 · Cited by 968
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., & Taylor, D. R. (1990) · Nature · doi:10.1038/343076a0 · Cited by 895
Efficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Malcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Mutations in SBDS are associated with Shwachman–Diamond syndrome
Boocock, G. R. B., Morrison, J. A., Popovic, M., Richards, N., Ellis, L., Durie, P. R., & Rommens, J. M. (2003) · Nature Genetics · doi:10.1038/ng1062 · Cited by 796
Kantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Self-citationCancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 615
Self-citationRole of nucleophosmin in embryonic development and tumorigenesis
Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L., Manova, K., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03915 · Cited by 561
Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0080 · Cited by 474
Garcia-Manero, G., Kantarjian, H. M., Sanchez-Gonzalez, B., Yang, H., Rosner, G., Verstovsek, S., Rytting, M., Wierda, W. G., Ravandi, F., Koller, C., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009142 · Cited by 467
Self-citationHellström‐Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I. M. S., Dybedal, I., Grimfors, G., Hesse‐Sundin, E., Hjorth, M., Kanter‐Lewensohn, L., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04153.x · Cited by 458
Dong, F., Brynes, R. K., Tidow, N., Welte, K., Löwenberg, B., & Touw, I. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330804 · Cited by 449
Dyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification
Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P. H., Cordon-Cardo, C., & Pandolfi, P. P. (2003) · Science · doi:10.1126/science.1079447 · Cited by 435
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes
Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2135 · Cited by 423
The survival kinases Akt and Pim as potential pharmacological targets
Amaravadi, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26273 · Cited by 408
Molecular pathogenesis of Fanconi anemia: recent progress
Taniguchi, T., & D'Andrea, A. D. (2006) · Blood · doi:10.1182/blood-2005-10-4240 · Cited by 393
Parker, J. E., Mufti, G. J., Rasool, F., Mijovic, A., Devereux, S., & Pagliuca, A. (2000) · Blood · doi:10.1182/blood.v96.12.3932 · Cited by 363
Association of CYP 3 A 4 genotype with treatment-related leukemia
Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N.-K. V., Lovett, B. D., Nowell, P. C., Blair, I. A., & Rebbeck, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13176 · Cited by 310
Harada, H., Harada, Y., Niimi, H., Kyo, T., Kimura, A., & Inaba, T. (2004) · Blood · doi:10.1182/blood-2003-09-3074 · Cited by 281
Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., & Morgan, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191211198 · Cited by 268
Nilsson, L., Åstrand-Grundström, I., Arvidsson, I., Jacobsson, B., Hellström-Lindberg, E., Hast, R., & Jacobsen, S. E. W. (2000) · Blood · doi:10.1182/blood.v96.6.2012 · Cited by 241
Ancliff, P. J., Blundell, M. P., Cory, G. O., Calle, Y., Worth, A., Kempski, H., Burns, S., Jones, G. E., Sinclair, J., Kinnon, C., et al. (2006) · Blood · doi:10.1182/blood-2006-01-010249 · Cited by 231
Lin, Y.-W., Slape, C., Zhang, Z., & Aplan, P. D. (2005) · Blood · doi:10.1182/blood-2004-12-4794 · Cited by 230
Kuendgen, A., Schmid, M., Schlenk, R., Knipp, S., Hildebrandt, B., Steidl, C., Germing, U., Haas, R., Dohner, H., & Gattermann, N. (2006) · Cancer · doi:10.1002/cncr.21552 · Cited by 224
EVI1 induces myelodysplastic syndrome in mice
Buonamici, S., Li, D., Chi, Y., Zhao, R., Wang, X., Brace, L., Ni, H., Saunthararajah, Y., & Nucifora, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21716 · Cited by 181
Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene
Meyn, M. S. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550501.x · Cited by 176
Kardos, G. (2003) · Blood · doi:10.1182/blood-2002-11-3444 · Cited by 174
Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J. P., Kajigaya, S., Sloand, E. M., & Young, N. S. (2004) · Blood · doi:10.1182/blood-2004-01-0103 · Cited by 172
Ribosomes and marrow failure: coincidental association or molecular paradigm?
Liu, J. M., & Ellis, S. R. (2006) · Blood · doi:10.1182/blood-2005-12-4831 · Cited by 166
Nilsson, L., Åstrand-Grundström, I., Anderson, K., Arvidsson, I., Hokland, P., Bryder, D., Kjeldsen, L., Johansson, B., Hellström-Lindberg, E., Hast, R., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0188 · Cited by 163
Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., Engert, A., & Diehl, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.160 · Cited by 161
Harada, H., Harada, Y., Tanaka, H., Kimura, A., & Inaba, T. (2002) · Blood · doi:10.1182/blood-2002-04-1010 · Cited by 160
Offman, J., Opelz, G., Doehler, B., Cummins, D., Halil, O., Banner, N. R., Burke, M. M., Sullivan, D., Macpherson, P., & Karran, P. (2004) · Blood · doi:10.1182/blood-2003-11-3938 · Cited by 158
Claessens, Y.-É., Bouscary, D., Dupont, J., Picard, F., Melle, J., Gisselbrecht, S., Lacombe, C., Dreyfus, F., Mayeux, P., & Fontenay, M. (2002) · Blood · doi:10.1182/blood.v99.5.1594 · Cited by 154
Greenberg, P. L., Young, N. S., & Gattermann, N. (2002) · Hematology · doi:10.1182/asheducation-2002.1.136 · Cited by 153
The WHO classification of MDS does make a difference
Howe, R. B., Porwit‐MacDonald, A., Wanat, R., Tehranchi, R., & Hellström-Lindberg, E. (2003) · Blood · doi:10.1182/blood-2003-06-2124 · Cited by 147
Hematopoiesis : a developmental approach
Zon, L. I. (2001) · Oxford University Press eBooks · Cited by 136
Tehranchi, R., Fadeel, B., Forsblom, A., Christensson, B., Samuelsson, J., Zhivotovsky, B., & Hellström‐Lindberg, E. (2003) · Blood · doi:10.1182/blood-2002-06-1774 · Cited by 133
Myelodysplastic syndrome is not merely “preleukemia”
Albitar, M. X., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H. M., Rogers, A. M., Jilani, I. B., Lin, C., Pierce, S. A., et al. (2002) · Blood · doi:10.1182/blood.v100.3.791 · Cited by 129
Self-citationList, A. F., Vardiman, J. W., Issa, J. J., & deWitte, T. (2004) · Hematology · doi:10.1182/asheducation-2004.1.297 · Cited by 125
Zang, D. Y., Goodwin, R. G., Loken, M. R., Bryant, E. M., & Deeg, H. J. (2001) · Blood · doi:10.1182/blood.v98.10.3058 · Cited by 122
Greenberg, P. L. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00112-x · Cited by 121
A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies
Rosenfeld, C. S., & List, A. F. (2000) · Leukemia · doi:10.1038/sj.leu.2401618 · Cited by 119
Dror, Y., & Freedman, M. H. (2001) · Blood · doi:10.1182/blood.v97.10.3011 · Cited by 118
Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia
Kook, H., Zeng, W., Chen, G., Kirby, M., Young, N. S., & Maciejewski, J. P. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00736-6 · Cited by 114
Aul, C., Giagounidis, A. A. N., & Germing, U. (2001) · International Journal of Hematology · doi:10.1007/bf02994001 · Cited by 107
Matsuda, A., Germing, U., Jinnai, I., Misumi, M., Kuendgen, A., Knipp, S., Aivado, M. A., Iwanaga, M., Miyazaki, Y., Tsushima, H., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0040 · Cited by 106
Tehranchi, R. (2005) · Blood · doi:10.1182/blood-2004-12-4649 · Cited by 104
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes
Raza, A. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<229::aid-jemt6>3.0.co;2-h · Cited by 101
Betti, C. J., Villalobos, M. J., Díaz, M. O., & Vaughan, A. T. (2001) · PubMed · Cited by 99
Thanopoulou, E., Cashman, J. D., Kakagianne, T., Eaves, A. C., Zoumbos, N. C., & Eaves, C. J. (2004) · Blood · doi:10.1182/blood-2003-09-3192 · Cited by 98
Crump, M., Tu, D., Shepherd, L. E., Levine, M., Bramwell, V. H. C., & Pritchard, K. I. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.137 · Cited by 91
Gazda, H. T., Kho, A. T., Sanoudou, D., Zaucha, J. M., Kohane, I. S., Sieff, C. A., & Beggs, A. H. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0554 · Cited by 88
Allampallam, K., Shetty, V. T., Mundle, S. D., Dutt, D., Kravitz, H. M., Reddy, P. L., Alvi, S., Galili, N., Saberwal, G. S., Anthwal, S., et al. (2002) · International Journal of Hematology · doi:10.1007/bf02982044 · Cited by 88
Campioni, D., Secchiero, P., Corallini, F., Melloni, E., Capitani, S., Lanza, F., & Zauli, G. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62277-8 · Cited by 88
Human mismatch repair, drug-induced DNA damage, and secondary cancer
Karran, P. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.007 · Cited by 85
Role of the CD95/CD95 Ligand System in Glucocorticoid-Induced Monocyte Apoptosis
Schmidt, M., Lügering, N., Lügering, A., Pauels, H., Schulze‐Osthoff, K., Domschke, W., & Kucharzik, T. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1344 · Cited by 83
Shetty, V. T., Hussaini, S., Broady-Robinson, L., Allampallam, K., Mundle, S. D., Borok, R. Z., Broderick, E., Mazzoran, L., Zorat, F., & Raza, A. (2000) · Blood · doi:10.1182/blood.v96.4.1388 · Cited by 79
Payvandi, F., Wu, L., Haley, M., Schafer, P. H., Zhang, L., Chen, R. S., Muller, G. W., & Stirling, D. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.09.003 · Cited by 77
Fontenay, M., Bouscary, D., Guesnu, M., Picard, F., Melle, J., Lacombe, C., Gisselbrecht, S., Mayeux, P., & Dreyfus, F. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01539.x · Cited by 74
Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.
Betti, C. J., Villalobos, M. J., Dı́az, M. O., & Vaughan, A. T. (2003) · PubMed · Cited by 73
The chemotaxis defect of Shwachman‐Diamond Syndrome leukocytes
Stepanovic, V., Wessels, D. J., Goldman, F. D., Geiger, J., & Soll, D. R. (2004) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.10164 · Cited by 72
Claessens, Y.-É., Park, S., Dubart‐Kupperschmitt, A., Mariot, V., Garrido, C., Chrétien, S., Dreyfus, F., Lacombe, C., Mayeux, P., & Fontenay, M. (2005) · Blood · doi:10.1182/blood-2004-08-3166 · Cited by 66
Lindberg, E. H., Schmidt‐Mende, J., Forsblom, A., Christensson, B., Fadeel, B., & Zhivotovsky, B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02581.x · Cited by 62
Wessels, D. J., Srikantha, T., Song, Y., Kuhl, S., Aravind, L., & Soll, D. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.02753 · Cited by 58
Benito, A. I., Bryant, E. M., Loken, M. R., Sale, G. E., Nash, R. A., Gass, M. J., & Deeg, H. J. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00221-7 · Cited by 58
Kerbauy, D. M. B., Lesnikov, V. A., Torok‐Storb, B., Bryant, E. M., & Deeg, H. J. (2004) · Blood · doi:10.1182/blood-2004-04-1518 · Cited by 55
Remicade as TNF Suppressor in Patients with Myelodysplastic Syndromes
Raza, A., Candoni, A., Khan, U. A., Lisak, L., Tahir, S. H., Silvestri, F., Billmeier, J., Alvi, M. I., Mumtaz, M. A., Gezer, S., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001723322 · Cited by 54
Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes
Tauro, S., Hepburn, M., Peddie, C. D., Bowen, D., & Pippard, M. J. (2002) · Leukemia · doi:10.1038/sj.leu.2402440 · Cited by 49
Asano, H., Ohashi, H., Ichihara, M., Kinoshita, T., Murate, T., Kobayashi, M., Saito, H., & Hotta, T. (1994) · Blood · doi:10.1182/blood.v84.2.588.588 · Cited by 48
Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein.
Chiocchetti, A., Gibello, L., Carando, A., Aspesi, A., Secco, P., Garelli, E., Loreni, F., Angelini, M., Biava, A., Dahl, N., et al. (2005) · PubMed · Cited by 45
Sato, T., Kim, S., Selleri, C., Young, N. S., & Maciejewski, J. P. (1998) · Leukemia · doi:10.1038/sj.leu.2401084 · Cited by 45
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
Xie, Y., de Winter, J. P., Waisfisz, Q., Nieuwint, A. W. M., Scheper, R. J., Arwert, F., Hoatlin, M. E., Ossenkoppele, G. J., Schuurhuis, G., & Joenje, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02450.x · Cited by 43
Epipodophyllotoxins in the treatment of childhood cancer
Rivera, G. K., Pui, C., Santana, V. M., Pratt, C. B., & Crist, W. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684870 · Cited by 42
The Hematopoietic Stem Cell in Myelodysplasia
Liesveld, J. L., Jordan, C. T., & Phillips, G. L. (2004) · Stem Cells · doi:10.1634/stemcells.22-4-590 · Cited by 40
Horwitz, M. S., Benson, K. F., Duan, Z., Person, R., Wechsler, J., Williams, K., Albani, D., & Li, F. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00008 · Cited by 38
Tehranchi, R., Fadeel, B., Schmidt‐Mende, J., Forsblom, A., Emanuelsson, E. K., Jädersten, M., Christensson, B., Hast, R., Howe, R. B., Samuelsson, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1850 · Cited by 38
Olipitz, W., Hopfinger, G., Aguiar, R. C. T., Gunsilius, E., Girschikofsky, M., Bodner, C., Hiden, K., Linkesch, W., Höefler, G., & Sill, H. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10059 · Cited by 33
Papadaki, H. Α., & Eliopoulos, G. D. (2003) · Cell Cycle · doi:10.4161/cc.2.5.463 · Cited by 29
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects
Maserati, E., Minelli, A., Menna, G., Cecchini, M. P., Bernardo, M. E., Rossi, G., Filippi, P. D., Curto, F. L., Danesino, C., Locatelli, F., et al. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00271-1 · Cited by 18
Fenaux, P., & Kelaïdi, C. (2006) · Hematology · doi:10.1182/asheducation-2006.1.192 · Cited by 16
Moody, J. L., & Jirik, F. R. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01901.x · Cited by 12
Meyer, S., Barber, L. M., White, D. J., Will, A., Birch, J. M., Kohler, J., Ersfeld, K., Blom, E., Joenje, H., Eden, T. O. B., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05985.x · Cited by 9
Cited by
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
Kramer, P. A., Ravi, S., Chacko, B., Johnson, M. S., & Darley-Usmar, V. M. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.026 · Cited by 413
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Dey, A., Seshasayee, D., Noubade, R., French, D. M., Liu, J., Chaurushiya, M. S., Kirkpatrick, D. S., Pham, V. C., Lill, J. R., Bakalarski, C. E., et al. (2012) · Science · doi:10.1126/science.1221711 · Cited by 412
Metadata
- Authors
- Corey, S. J., Minden, M. D., Barber, D. L., Kantarjian, H., Wang, J. C. Y., & Schimmer, A. D.
- Venue
- Nature Reviews Cancer
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 118-129
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2013781993
- Cited by
- 342
- References
- 97
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.